Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQV6W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,758
Award facts
- Contract value 100% obligated
- $19,758.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,758.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. The contract is non-set-aside and competitively awarded, with performance to be completed by February 20, 2026, at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply agreement valued through December 31, 2031, that enables the company to supply a broad range of medications and medical commodities to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its established relationship with DLA's Medical Supply Chain. Tezspire is a specialty biologic medication indicated for moderate-to-severe eosinophilic asthma, reflecting the company's role in delivering specialized therapeutic pharmaceuticals across multiple disease states to military treatment facilities and defense health operations. The competitive, non-set-aside nature of this award demonstrates AmerisourceBergen's capability to meet federal procurement standards through open competition for essential medical supplies supporting Department of Defense healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FQV6W?
SPE2DR26FQV6W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FQV6W worth?
The government has obligated $19,758 on SPE2DR26FQV6W.
Is contract SPE2DR26FQV6W an order under another contract?
Yes. SPE2DR26FQV6W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV6W competed?
The extent of competition for SPE2DR26FQV6W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award